Association of pan-immune inflammation value with mortality in patients with pulmonary embolism: a cohort study.

ABSTRACT: Pan-immune inflammation value (PIV) is associated with prognosis in immune and inflammatory diseases, and inflammation is a hallmark of pulmonary embolism (PE). Nonetheless, the link between PIV and prognosis in PE remains unclear. However, few studies have specifically focused on critically ill patients with PE in ICUs. This study retrospectively analyzed electronic health data of patients with PE from the Medical Information Mart for Intensive Care (MIMIC-IV) database. The primary outcome was 28-day ACM; secondary outcomes were 90-day, 1-year, ICU, and in-hospital mortality. The study population included 213 patients with PE. Multivariate Cox proportional hazards regression showed that elevated PIV was significantly associated with ACM at 28 days (adjusted hazard ratio [aHR]: 1.93; 95% c

SUBMITTER: Zhao W 

PROVIDER: S-EPMC11850865 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature